Tumor dormancy therapy for the human adenoid cystic carcinoma
Project/Area Number |
21792009
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Single-year Grants |
Research Field |
Surgical dentistry
|
Research Institution | Ehime University |
Principal Investigator |
SUMIDA Tomoki Ehime University, 医学部附属病院, 講師 (50314951)
|
Project Period (FY) |
2009 – 2010
|
Project Status |
Completed (Fiscal Year 2010)
|
Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2010: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2009: ¥2,990,000 (Direct Cost: ¥2,300,000、Indirect Cost: ¥690,000)
|
Keywords | 腺様嚢胞癌 / ID1 / エストロゲンレセプター / アンドロゲンレセプター |
Research Abstract |
In this study, we confirmed that hormonal therapy and Id1 targeting therapy could reduce the growth and invasion of adenoid cystic carcinoma cells. These results indicate that this strategy has a potential for the tumor dormancy therapy for the human adenoid cystic carcinoma.
|
Report
(3 results)
Research Products
(9 results)